Perspective Therapeutics, Inc. (CATX) AMEX
3.56
-0.04(-1.11%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.56
-0.04(-1.11%)
Currency In USD
| Market Cap | 202.99M |
| Enterprise Value | 173.98M |
| P/E Ratio | -3.32 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 478.28 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 388.97 |
| Enterprise/EBITDA | -2.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -193.27 |
| Operating Margin | -208.72 |
| Return On Assets | -0.27 |
| Return On Equity | -0.42 |
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | 0 |
| EBITDA | -100.8M |
| Net Income | -103.12M |
| Diluted EPS | -1.4 |
| Total Cash | 270.93M |
| Total Cash/Share | 2.62 |
| Total Debt | 2.62M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.75 |
| Book Value Per Share | 3.35 |
| 52-Week Change | 15.21 |
| 52-Week High | 6.16 |
| 52-Week Low | 1.96 |
| Moving Average 50 Days | 4.1 |
| Moving Average 200 Days | 3.62 |
| Average Volume | 1.41M |
| Shares Outstanding | 77.25M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 17, 2024 |